{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T08:00:24Z","timestamp":1721808024068},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T00:00:00Z","timestamp":1510099200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00115-017-0444-6","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T04:24:24Z","timestamp":1510115064000},"page":"1411-1420","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Optische Koh\u00e4renztomographie bei Neuromyelitis optica-Spektrum-Erkrankungen"],"prefix":"10.1007","volume":"88","author":[{"given":"F. C.","family":"Oertel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. U.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,8]]},"reference":[{"key":"444_CR1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jneuroim.2016.09.007","volume":"299","author":"T Akaishi","year":"2016","unstructured":"Akaishi T, Nakashima I, Takeshita T et\u00a0al (2016) Different etiologies and prognoses of optic neuritis in demyelinating diseases. J\u00a0Neuroimmunol 299:152\u2013157. \n                        https:\/\/doi.org\/10.1016\/j.jneuroim.2016.09.007","journal-title":"J Neuroimmunol"},{"key":"444_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/jnnp-2014-310206","volume":"87","author":"T Akaishi","year":"2016","unstructured":"Akaishi T, Sato DK, Nakashima I et al (2016) MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a\u00a0comparative study. J\u00a0Neurol Neurosurg Psychiatr 87:446\u2013448. \n                        https:\/\/doi.org\/10.1136\/jnnp-2014-310206","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"444_CR3","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1212\/NXI.0000000000000343","volume":"4","author":"N Asgari","year":"2017","unstructured":"Asgari N, Flanagan EP, Fujihara K et\u00a0al (2017) Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm 4:e343. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000343","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR4","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00415-015-7991-1","volume":"263","author":"I Ayzenberg","year":"2016","unstructured":"Ayzenberg I, Sch\u00f6llhammer J, Hoepner R et\u00a0al (2016) Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a\u00a0multicenter retrospective study. J\u00a0Neurol 263:575\u2013582. \n                        https:\/\/doi.org\/10.1007\/s00415-015-7991-1","journal-title":"J Neurol"},{"key":"444_CR5","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1212\/NXI.0000000000000277","volume":"3","author":"A Bar-Or","year":"2016","unstructured":"Bar-Or A, Steinman L, Behne JM et al (2016) Restoring immune tolerance in neuromyelitis optica: Part II. Neurol Neuroimmunol Neuroinflamm 3:e277. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000277","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR6","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1212\/NXI.0000000000000104","volume":"2","author":"JL Bennett","year":"2015","unstructured":"Bennett JL, O\u2019Connor KC, Bar-Or A et al (2015) B lymphocytes in neuromyelitis optica. Neurol Neuroimmunol Neuroinflamm 2:e104. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000104","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR7","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1177\/1352458514567216","volume":"21","author":"JL Bennett","year":"2015","unstructured":"Bennett JL, de Seze J, Lana-Peixoto M et al (2015) Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography. Mult Scler 21:678\u2013688. \n                        https:\/\/doi.org\/10.1177\/1352458514567216","journal-title":"Mult Scler"},{"key":"444_CR8","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1177\/1352458510365156","volume":"16","author":"M Bock","year":"2010","unstructured":"Bock M, Brandt AU, D\u00f6rr J et al (2010) Time domain and spectral domain optical coherence tomography in multiple sclerosis: a\u00a0comparative cross-sectional study. Mult Scler 16:893\u2013896. \n                        https:\/\/doi.org\/10.1177\/1352458510365156","journal-title":"Mult Scler"},{"key":"444_CR9","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00115-012-3707-2","volume":"84","author":"M Bock","year":"2013","unstructured":"Bock M, Paul F, D\u00f6rr J (2013) Diagnosis and monitoring of multiple sclerosis: the value of optical coherence tomography. Nervenarzt 84:483\u2013492. \n                        https:\/\/doi.org\/10.1007\/s00115-012-3707-2","journal-title":"Nervenarzt"},{"key":"444_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038741","author":"AU Brandt","year":"2012","unstructured":"Brandt AU, Zimmermann H, Kaufhold F et\u00a0al (2012) Patterns of retinal damage facilitate differential diagnosis between Susac syndrome and MS. PLOS ONE. \n                        https:\/\/doi.org\/10.1371\/journal.pone.0038741","journal-title":"PLOS ONE"},{"key":"444_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1212\/WNL.0000000000000545","volume":"83","author":"AU Brandt","year":"2014","unstructured":"Brandt AU, Oberwahrenbrock T, Kadas EM et\u00a0al (2014) Dynamic formation of macular microcysts independent of vitreous traction changes. Neurology 83:73\u201377. \n                        https:\/\/doi.org\/10.1212\/WNL.0000000000000545","journal-title":"Neurology"},{"key":"444_CR12","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/IAE.0000000000000700","volume":"36","author":"AU Brandt","year":"2016","unstructured":"Brandt AU, Oberwahrenbrock T, Costello F et\u00a0al (2016) Retinal lesion evolution in Susac syndrome. Retina 36:366\u2013374. \n                        https:\/\/doi.org\/10.1097\/IAE.0000000000000700","journal-title":"Retina"},{"key":"444_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1055\/s-0042-124610","volume":"44","author":"AU Brandt","year":"2017","unstructured":"Brandt AU, Zimmermann H, Scheel M et\u00a0al (2017) Untersuchungen des visuellen Systems in der Neurologie: aktuelle Forschung und klinische Relevanz. Akt Neurol 44:27\u201345. \n                        https:\/\/doi.org\/10.1055\/s-0042-124610","journal-title":"Akt Neurol"},{"key":"444_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000081203","volume":"36","author":"A Bringmann","year":"2004","unstructured":"Bringmann A, Reichenbach A, Wiedemann P (2004) Pathomechanisms of cystoid macular edema. Ophthalmic Res 36:241\u2013249. \n                        https:\/\/doi.org\/10.1159\/000081203","journal-title":"Ophthalmic Res"},{"key":"444_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-017-8531-y","author":"J Britze","year":"2017","unstructured":"Britze J, Pihl-Jensen G, Frederiksen JL (2017) Retinal ganglion cell analysis in multiple sclerosis and optic neuritis: a\u00a0systematic review and meta-analysis. J\u00a0Neurol. \n                        https:\/\/doi.org\/10.1007\/s00415-017-8531-y","journal-title":"J Neurol"},{"key":"444_CR16","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1001\/archneurol.2009.230","volume":"66","author":"BM Burkholder","year":"2009","unstructured":"Burkholder BM, Osborne B, Loguidice MJ et\u00a0al (2009) Macular volume determined by optical coherence tomography as a\u00a0measure of neuronal loss in multiple sclerosis. Arch Neurol 66:1366\u20131372. \n                        https:\/\/doi.org\/10.1001\/archneurol.2009.230","journal-title":"Arch Neurol"},{"key":"444_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1474-4422(16)30377-5","volume":"16","author":"D Cadavid","year":"2017","unstructured":"Cadavid D, Balcer L, Galetta S et al (2017) Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a\u00a0randomised, placebo-controlled, phase 2 trial. Lancet Neurol 16:189\u2013199. \n                        https:\/\/doi.org\/10.1016\/S1474-4422(16)30377-5","journal-title":"Lancet Neurol"},{"key":"444_CR18","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1212\/NXI.0000000000000131","volume":"2","author":"K Chalmoukou","year":"2015","unstructured":"Chalmoukou K, Alexopoulos H, Akrivou S et al (2015) Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis. Neurol Neuroimmunol Neuroinflamm 2:e131. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000131","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR19","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.1212\/NXI.0000000000000286","volume":"3","author":"VS Chavarro","year":"2016","unstructured":"Chavarro VS, Mealy MA, Simpson A et\u00a0al (2016) Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm 3:e286. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000286","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ncl.2016.08.012","volume":"35","author":"F Costello","year":"2017","unstructured":"Costello F (2017) Optical coherence tomography in neuro-ophthalmology. Neurol Clin 35:153\u2013163. \n                        https:\/\/doi.org\/10.1016\/j.ncl.2016.08.012","journal-title":"Neurol Clin"},{"key":"444_CR21","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ana.20851","volume":"59","author":"F Costello","year":"2006","unstructured":"Costello F, Coupland S, Hodge W et\u00a0al (2006) Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 59:963\u2013969. \n                        https:\/\/doi.org\/10.1002\/ana.20851","journal-title":"Ann Neurol"},{"key":"444_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-309704","author":"F Costello","year":"2015","unstructured":"Costello F, Pan YI, Yeh EA et\u00a0al (2015) The temporal evolution of structural and functional measures after acute optic neuritis. J\u00a0Neurol Neurosurg Psychiatr. \n                        https:\/\/doi.org\/10.1136\/jnnp-2014-309704","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"444_CR23","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1177\/1352458515620934","volume":"22","author":"BA Cree","year":"2016","unstructured":"Cree BA, Bennett JL, Sheehan M et al (2016) Placebo-controlled study in neuromyelitis optica-ethical and design considerations. Mult Scler 22:862\u2013872. \n                        https:\/\/doi.org\/10.1177\/1352458515620934","journal-title":"Mult Scler"},{"key":"444_CR24","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1212\/WNL.0000000000002774","volume":"86","author":"A Cruz-Herranz","year":"2016","unstructured":"Cruz-Herranz A, Balk LJ, Oberwahrenbrock T et al (2016) The APOSTEL recommendations for reporting quantitative optical coherence tomography studies. Neurology 86:2303\u20132309. \n                        https:\/\/doi.org\/10.1212\/WNL.0000000000002774","journal-title":"Neurology"},{"key":"444_CR25","doi-asserted-by":"publisher","first-page":"e345","DOI":"10.1212\/NXI.0000000000000345","volume":"4","author":"J Dalmau","year":"2017","unstructured":"Dalmau J (2017) Precision in neuroimmunology. Neurol Neuroimmunol Neuroinflamm 4:e345. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000345","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR26","doi-asserted-by":"publisher","first-page":"e010956","DOI":"10.1136\/bmjopen-2015-010956","volume":"6","author":"R Diem","year":"2016","unstructured":"Diem R, Molnar F, Beisse F et al (2016) Treatment of optic neuritis with erythropoietin (TONE): a\u00a0randomised, double-blind, placebo-controlled trial-study protocol. BMJ Open 6:e10956. \n                        https:\/\/doi.org\/10.1136\/bmjopen-2015-010956","journal-title":"BMJ Open"},{"key":"444_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1745-6215-13-15","volume":"13","author":"J D\u00f6rr","year":"2012","unstructured":"D\u00f6rr J, Ohlraun S, Skarabis H, Paul F (2012) Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a\u00a0randomized controlled trial. Trials 13:15. \n                        https:\/\/doi.org\/10.1186\/1745-6215-13-15","journal-title":"Trials"},{"key":"444_CR28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12974-016-0746-9","volume":"13","author":"CM Felix","year":"2016","unstructured":"Felix CM, Levin MH, Verkman AS (2016) Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G. J\u00a0Neuroinflammation 13:275. \n                        https:\/\/doi.org\/10.1186\/s12974-016-0746-9","journal-title":"J Neuroinflammation"},{"key":"444_CR29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0002-9394(14)71762-3","volume":"116","author":"AF Fercher","year":"1993","unstructured":"Fercher AF, Hitzenberger CK, Drexler W et\u00a0al (1993) In vivo optical coherence tomography. Am J Ophthalmol 116:113\u2013114","journal-title":"Am J Ophthalmol"},{"key":"444_CR30","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ophtha.2012.07.066","volume":"120","author":"DB Fernandes","year":"2013","unstructured":"Fernandes DB, Raza AS, Nogueira R et\u00a0al (2013) Evaluation of inner retinal layers in patients with multiple sclerosis or neuromyelitis optica using optical coherence tomography. Ophthalmology 120:387\u2013394. \n                        https:\/\/doi.org\/10.1016\/j.ophtha.2012.07.066","journal-title":"Ophthalmology"},{"key":"444_CR31","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.1212\/NXI.0000000000000229","volume":"3","author":"C Finke","year":"2016","unstructured":"Finke C, Heine J, Pache F et\u00a0al (2016) Normal volumes and microstructural integrity of deep gray matter structures in AQP4+ NMOSD. Neurol Neuroimmunol Neuroinflamm 3:e229. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000229","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR32","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1167\/iovs.08-2113","volume":"49","author":"F Forooghian","year":"2008","unstructured":"Forooghian F, Cukras C, Meyerle CB et\u00a0al (2008) Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema. Invest Ophthalmol Vis Sci 49:4290\u20134296. \n                        https:\/\/doi.org\/10.1167\/iovs.08-2113","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"444_CR33","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1212\/WNL.0b013e3182661edc","volume":"79","author":"AR Frohman","year":"2012","unstructured":"Frohman AR, Schnurman Z, Conger A et\u00a0al (2012) Multifocal visual evoked potentials are influenced by variable contrast stimulation in MS. Neurology 79:797\u2013801. \n                        https:\/\/doi.org\/10.1212\/WNL.0b013e3182661edc","journal-title":"Neurology"},{"key":"444_CR34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ana.24030","volume":"75","author":"I Gabilondo","year":"2014","unstructured":"Gabilondo I, Mart\u00ednez-Lapiscina EH, Mart\u00ednez-Heras E et al (2014) Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Ann Neurol 75:98\u2013107. \n                        https:\/\/doi.org\/10.1002\/ana.24030","journal-title":"Ann Neurol"},{"key":"444_CR35","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.24351","volume":"77","author":"I Gabilondo","year":"2015","unstructured":"Gabilondo I, Mart\u00ednez-Lapiscina EH, Fraga-Pumar E et al (2015) Dynamics of retinal injury after acute optic neuritis. Ann Neurol 77:517\u2013528. \n                        https:\/\/doi.org\/10.1002\/ana.24351","journal-title":"Ann Neurol"},{"key":"444_CR36","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/WNO.0b013e318240204d","volume":"32","author":"KM Galetta","year":"2012","unstructured":"Galetta KM, Graves J, Talman LS et\u00a0al (2012) Visual pathway axonal loss in benign multiple sclerosis: a\u00a0longitudinal study. J\u00a0Neuroophthalmol 32:116\u2013123. \n                        https:\/\/doi.org\/10.1097\/WNO.0b013e318240204d","journal-title":"J Neuroophthalmol"},{"key":"444_CR37","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1212\/NXI.0000000000000135","volume":"2","author":"SL Galetta","year":"2015","unstructured":"Galetta SL, Villoslada P, Levin N et\u00a0al (2015) Acute optic neuritis: unmet clinical needs and model for new therapies. Neurol Neuroimmunol Neuroinflamm 2:e135. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000135","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR38","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1093\/brain\/aws098","volume":"135","author":"JM Gelfand","year":"2012","unstructured":"Gelfand JM, Nolan R, Schwartz DM et\u00a0al (2012) Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain 135:1786\u20131793. \n                        https:\/\/doi.org\/10.1093\/brain\/aws098","journal-title":"Brain"},{"key":"444_CR39","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1001\/jamaneurol.2013.1832","volume":"70","author":"JM Gelfand","year":"2013","unstructured":"Gelfand JM, Cree BA, Nolan R et\u00a0al (2013) Microcystic inner nuclear layer abnormalities and neuromyelitis optica. JAMA Neurol 70:629\u2013633. \n                        https:\/\/doi.org\/10.1001\/jamaneurol.2013.1832","journal-title":"JAMA Neurol"},{"key":"444_CR40","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1212\/NXI.0000000000000034","volume":"1","author":"JM Gelfand","year":"2014","unstructured":"Gelfand JM, Cotter J, Klingman J et al (2014) Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO. Neurol Neuroimmunol Neuroinflamm 1:e34. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000034","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR41","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1177\/1352458513519838","volume":"20","author":"F Glehn von","year":"2014","unstructured":"von Glehn F, Jarius S, Cavalcanti Lira RP et\u00a0al (2014) Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders. Mult Scler 20:1189\u20131197. \n                        https:\/\/doi.org\/10.1177\/1352458513519838","journal-title":"Mult Scler"},{"key":"444_CR42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00415-016-8333-7","volume":"264","author":"J Havla","year":"2017","unstructured":"Havla J, K\u00fcmpfel T, Schinner R et al (2017) Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration. J\u00a0Neurol 264:139\u2013151. \n                        https:\/\/doi.org\/10.1007\/s00415-016-8333-7","journal-title":"J Neurol"},{"key":"444_CR43","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/1352458515586084","volume":"22","author":"L Hertwig","year":"2016","unstructured":"Hertwig L, Pache F, Romero-Suarez S et al (2016) Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica. Mult Scler 22:160\u2013173. \n                        https:\/\/doi.org\/10.1177\/1352458515586084","journal-title":"Mult Scler"},{"key":"444_CR44","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/ana.24608","volume":"79","author":"M Hokari","year":"2016","unstructured":"Hokari M, Yokoseki A, Arakawa M et\u00a0al (2016) Clinicopathological features in anterior visual pathway in neuromyelitis optica. Ann Neurol 79:605\u2013624. \n                        https:\/\/doi.org\/10.1002\/ana.24608","journal-title":"Ann Neurol"},{"key":"444_CR45","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1212\/WNL.0b013e3182929fd5","volume":"80","author":"L Horton","year":"2013","unstructured":"Horton L, Conger A, Conger D et al (2013) Effect of 4\u2011aminopyridine on vision in multiple sclerosis patients with optic neuropathy. Neurology 80:1862\u20131866. \n                        https:\/\/doi.org\/10.1212\/WNL.0b013e3182929fd5","journal-title":"Neurology"},{"key":"444_CR46","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1126\/science.1957169","volume":"254","author":"D Huang","year":"1991","unstructured":"Huang D, Swanson EA, Lin CP et\u00a0al (1991) Optical coherence tomography. Science 254:1178\u20131181","journal-title":"Science"},{"key":"444_CR47","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/ncpneuro0764","volume":"4","author":"S Jarius","year":"2008","unstructured":"Jarius S, Paul F, Franciotta D et al (2008) Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 4:202\u2013214. \n                        https:\/\/doi.org\/10.1038\/ncpneuro0764","journal-title":"Nat Clin Pract Neurol"},{"key":"444_CR48","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","volume":"306","author":"S Jarius","year":"2011","unstructured":"Jarius S, Paul F, Franciotta D et al (2011) Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J\u00a0Neurol Sci 306:82\u201390. \n                        https:\/\/doi.org\/10.1016\/j.jns.2011.03.038","journal-title":"J Neurol Sci"},{"key":"444_CR49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jns.2012.06.002","volume":"320","author":"S Jarius","year":"2012","unstructured":"Jarius S, Franciotta D, Paul F et al (2012) Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry. J\u00a0Neurol Sci 320:32\u201337. \n                        https:\/\/doi.org\/10.1016\/j.jns.2012.06.002","journal-title":"J Neurol Sci"},{"key":"444_CR50","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/cei.12271","volume":"176","author":"S Jarius","year":"2014","unstructured":"Jarius S, Wildemann B, Paul F (2014) Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol 176:149\u2013164. \n                        https:\/\/doi.org\/10.1111\/cei.12271","journal-title":"Clin Exp Immunol"},{"key":"444_CR51","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12974-016-0719-z","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Kleiter I, Ruprecht K et al (2016) MOG-IgG in NMO and related disorders: a\u00a0multicenter study of 50 patients. Part 3: brainstem involvement \u2013 frequency, presentation and outcome. J\u00a0Neuroinflammation 13:281. \n                        https:\/\/doi.org\/10.1186\/s12974-016-0719-z","journal-title":"J Neuroinflammation"},{"key":"444_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0718-0","author":"S Jarius","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I et al (2016) MOG-IgG in NMO and related disorders: a\u00a0multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J\u00a0Neuroinflammation. \n                        https:\/\/doi.org\/10.1186\/s12974-016-0718-0","journal-title":"J Neuroinflammation"},{"key":"444_CR53","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12974-016-0717-1","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I et al (2016) MOG-IgG in NMO and related disorders: a\u00a0multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. J\u00a0Neuroinflammation 13:279. \n                        https:\/\/doi.org\/10.1186\/s12974-016-0717-1","journal-title":"J Neuroinflammation"},{"key":"444_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8138-8","author":"IH Jeong","year":"2016","unstructured":"Jeong IH, Kim HJ, Kim N\u2011H et al (2016) Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder. J\u00a0Neurol. \n                        https:\/\/doi.org\/10.1007\/s00415-016-8138-8","journal-title":"J Neurol"},{"key":"444_CR55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/WCO.0b013e328334e99b","volume":"23","author":"P Jindahra","year":"2010","unstructured":"Jindahra P, Hedges TR, Mendoza-Santiesteban CE, Plant GT (2010) Optical coherence tomography of the retina: applications in neurology. Curr Opin Neurol 23:16\u201323. \n                        https:\/\/doi.org\/10.1097\/WCO.0b013e328334e99b","journal-title":"Curr Opin Neurol"},{"key":"444_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071145","author":"F Kaufhold","year":"2013","unstructured":"Kaufhold F, Zimmermann H, Schneider E et\u00a0al (2013) Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis. PLOS ONE. \n                        https:\/\/doi.org\/10.1371\/journal.pone.0071145","journal-title":"PLOS ONE"},{"key":"444_CR57","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","volume":"84","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Paul F, Lana-Peixoto MA et al (2015) MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology 84:1165\u20131173. \n                        https:\/\/doi.org\/10.1212\/WNL.0000000000001367","journal-title":"Neurology"},{"key":"444_CR58","doi-asserted-by":"publisher","first-page":"398259","DOI":"10.1155\/2013\/398259","volume":"2013","author":"I Kister","year":"2013","unstructured":"Kister I, Herbert J, Zhou Y, Ge Y (2013) Ultrahigh-field MR (7\u202fT) imaging of brain lesions in neuromyelitis optica. Mult Scler Int 2013:398259. \n                        https:\/\/doi.org\/10.1155\/2013\/398259","journal-title":"Mult Scler Int"},{"key":"444_CR59","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1093\/brain\/aws109","volume":"135","author":"J Kitley","year":"2012","unstructured":"Kitley J, Leite MI, Nakashima I et al (2012) Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain 135:1834\u20131849. \n                        https:\/\/doi.org\/10.1093\/brain\/aws109","journal-title":"Brain"},{"key":"444_CR60","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1001\/archneurol.2011.216","volume":"69","author":"I Kleiter","year":"2012","unstructured":"Kleiter I, Hellwig K, Berthele A et\u00a0al (2012) Failure of natalizumab to prevent relapses in neuromyelitis optica. Arch Neurol 69:239\u2013245. \n                        https:\/\/doi.org\/10.1001\/archneurol.2011.216","journal-title":"Arch Neurol"},{"key":"444_CR61","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww219","author":"B Knier","year":"2016","unstructured":"Knier B, Schmidt P, Aly L et\u00a0al (2016) Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis. Brain. \n                        https:\/\/doi.org\/10.1093\/brain\/aww219","journal-title":"Brain"},{"key":"444_CR62","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1212\/NXI.0000000000000066","volume":"2","author":"MD Kornberg","year":"2015","unstructured":"Kornberg MD, Newsome SD (2015) Unmasking and provoking severe disease activity in a\u00a0patient with NMO spectrum disorder. Neurol Neuroimmunol Neuroinflamm 2:e66. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000066","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR63","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1212\/NXI.0000000000000335","volume":"4","author":"P K\u00f6rtv\u00e9lyessy","year":"2017","unstructured":"K\u00f6rtv\u00e9lyessy P, Breu M, Pawlitzki M et al (2017) ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports. Neurol Neuroimmunol Neuroinflamm 4:e335. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000335","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR64","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1001\/jamaneurol.2015.0248","volume":"72","author":"S Kremer","year":"2015","unstructured":"Kremer S, Renard F, Achard S et\u00a0al (2015) Use of advanced magnetic resonance imaging techniques in neuromyelitis optica spectrum disorder. JAMA Neurol 72:815\u2013822. \n                        https:\/\/doi.org\/10.1001\/jamaneurol.2015.0248","journal-title":"JAMA Neurol"},{"key":"444_CR65","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1212\/NXI.0000000000000134","volume":"2","author":"E Melamed","year":"2015","unstructured":"Melamed E, Levy M, Waters PJ et\u00a0al (2015) Update on biomarkers in neuromyelitis optica. Neurol Neuroimmunol Neuroinflamm 2:e134. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000134","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR66","doi-asserted-by":"publisher","first-page":"4412","DOI":"10.1167\/iovs.08-1815","volume":"49","author":"H Merle","year":"2008","unstructured":"Merle H, Olindo S, Donnio A et\u00a0al (2008) Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica. Invest Ophthalmol Vis Sci 49:4412\u20134417. \n                        https:\/\/doi.org\/10.1167\/iovs.08-1815","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"444_CR67","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1001\/archophthalmol.2012.1126","volume":"130","author":"H Merle","year":"2012","unstructured":"Merle H, Olindo S, Jeannin S et al (2012) Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica. Arch Ophthalmol 130:858\u2013862. \n                        https:\/\/doi.org\/10.1001\/archophthalmol.2012.1126","journal-title":"Arch Ophthalmol"},{"key":"444_CR68","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1212\/NXI.0000000000000204","volume":"3","author":"I Metz","year":"2016","unstructured":"Metz I, Bei\u00dfbarth T, Ellenberger D et\u00a0al (2016) Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 3:e204. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000204","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR69","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.1167\/iovs.11-9324","volume":"53","author":"MLR Monteiro","year":"2012","unstructured":"Monteiro MLR, Fernandes DB, Ap\u00f3stolos-Pereira SL, Callegaro D (2012) Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using Fourier-domain optical coherence tomography. Invest Ophthalmol Vis Sci 53:3959\u20133966. \n                        https:\/\/doi.org\/10.1167\/iovs.11-9324","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"444_CR70","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s00417-010-1344-7","volume":"248","author":"M Nakamura","year":"2010","unstructured":"Nakamura M, Nakazawa T, Doi H et al (2010) Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica. Graefes Arch Clin Exp Ophthalmol 248:1777\u20131785. \n                        https:\/\/doi.org\/10.1007\/s00417-010-1344-7","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"444_CR71","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1177\/1352458513489757","volume":"19","author":"T Oberwahrenbrock","year":"2013","unstructured":"Oberwahrenbrock T, Ringelstein M, Jentschke S et\u00a0al (2013) Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome. Mult Scler 19:1887\u20131895. \n                        https:\/\/doi.org\/10.1177\/1352458513489757","journal-title":"Mult Scler"},{"key":"444_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137316","author":"T Oberwahrenbrock","year":"2015","unstructured":"Oberwahrenbrock T, Weinhold M, Mikolajczak J et al (2015) Reliability of intra-retinal layer thickness estimates. PLOS ONE. \n                        https:\/\/doi.org\/10.1371\/journal.pone.0137316","journal-title":"PLOS ONE"},{"key":"444_CR73","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1212\/NXI.0000000000000334","volume":"4","author":"FC Oertel","year":"2017","unstructured":"Oertel FC, Kuchling J, Zimmermann H et al (2017) Microstructural visual system changes in AQP4-antibody\u2013seropositive NMOSD. Neurol Neuroimmunol Neuroinflamm 4:e334. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000334","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR74","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1212\/NXI.0000000000000338","volume":"4","author":"FC Oertel","year":"2017","unstructured":"Oertel FC, Zimmermann H, Mikolajczak J et\u00a0al (2017) Contribution of blood vessels to retinal nerve fiber layer thickness in NMOSD. Neurol Neuroimmunol Neuroinflamm 4:e338. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000338","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR75","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1177\/1352458515578888","volume":"21","author":"O Outteryck","year":"2015","unstructured":"Outteryck O, Majed B, Defoort-Dhellemmes S et al (2015) A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis. Mult Scler 21:1781\u20131793. \n                        https:\/\/doi.org\/10.1177\/1352458515578888","journal-title":"Mult Scler"},{"key":"444_CR76","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-016-4282-x","author":"F Pache","year":"2016","unstructured":"Pache F, Zimmermann H, Finke C et\u00a0al (2016) Brain parenchymal damage in neuromyelitis optica spectrum disorder \u2013 A multimodal MRI study. Eur Radiol. \n                        https:\/\/doi.org\/10.1007\/s00330-016-4282-x","journal-title":"Eur Radiol"},{"key":"444_CR77","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12974-016-0720-6","volume":"13","author":"F Pache","year":"2016","unstructured":"Pache F, Zimmermann H, Mikolajczak J et al (2016) MOG-IgG in NMO and related disorders: a\u00a0multicenter study of 50 patients. Part 4: afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients. J\u00a0Neuroinflammation 13:282. \n                        https:\/\/doi.org\/10.1186\/s12974-016-0720-6","journal-title":"J Neuroinflammation"},{"key":"444_CR78","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1055\/s-0035-1567186","volume":"85","author":"F Pache","year":"2017","unstructured":"Pache F, Wildemann B, Paul F, Jarius S (2017) Neuromyelitis optica. Fortschr Neurol Psychiatr 85:e1. \n                        https:\/\/doi.org\/10.1055\/s-0035-1567186","journal-title":"Fortschr Neurol Psychiatr"},{"key":"444_CR79","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S1474-4422(13)70089-9","volume":"12","author":"F Paul","year":"2013","unstructured":"Paul F (2013) Hope for a\u00a0rare disease: eculizumab in neuromyelitis optica. Lancet Neurol 12:529\u2013531. \n                        https:\/\/doi.org\/10.1016\/S1474-4422(13)70089-9","journal-title":"Lancet Neurol"},{"key":"444_CR80","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1371\/journal.pmed.0040133","volume":"4","author":"F Paul","year":"2007","unstructured":"Paul F, Jarius S, Aktas O et\u00a0al (2007) Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med 4:e133. \n                        https:\/\/doi.org\/10.1371\/journal.pmed.0040133","journal-title":"PLoS Med"},{"key":"444_CR81","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrneurol.2014.108","volume":"10","author":"A Petzold","year":"2014","unstructured":"Petzold A, Wattjes MP, Costello F et\u00a0al (2014) The investigation of acute optic neuritis: a\u00a0review and proposed protocol. Nat Rev Neurol 10:447\u2013458. \n                        https:\/\/doi.org\/10.1038\/nrneurol.2014.108","journal-title":"Nat Rev Neurol"},{"key":"444_CR82","doi-asserted-by":"publisher","first-page":"e18019","DOI":"10.1371\/journal.pone.0018019","volume":"6","author":"CF Pfueller","year":"2011","unstructured":"Pfueller CF, Brandt AU, Schubert F et\u00a0al (2011) Metabolic changes in the visual cortex are linked to retinal nerve fiber layer thinning in multiple sclerosis. PLOS ONE 6:e18019. \n                        https:\/\/doi.org\/10.1371\/journal.pone.0018019","journal-title":"PLOS ONE"},{"key":"444_CR83","doi-asserted-by":"publisher","first-page":"869814","DOI":"10.1155\/2011\/869814","volume":"2011","author":"CF Pfueller","year":"2011","unstructured":"Pfueller CF, Paul F, Pfueller CF, Paul F (2011) Imaging the visual pathway in neuromyelitis optica, imaging the visual pathway in neuromyelitis optica. Mult Scler Int 2011:869814. \n                        https:\/\/doi.org\/10.1155\/2011\/869814","journal-title":"Mult Scler Int"},{"key":"444_CR84","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B et\u00a0al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292\u2013302. \n                        https:\/\/doi.org\/10.1002\/ana.22366","journal-title":"Ann Neurol"},{"key":"444_CR85","volume-title":"Central projections of retinal ganglion cells","author":"D Purves","year":"2001","unstructured":"Purves D, Augustine GJ, Fitzpatrick D et\u00a0al (2001) Central projections of retinal ganglion cells"},{"key":"444_CR86","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1474-4422(16)00004-1","volume":"15","author":"R Raftopoulos","year":"2016","unstructured":"Raftopoulos R, Hickman SJ, Toosy A et al (2016) Phenytoin for neuroprotection in patients with acute optic neuritis: a\u00a0randomised, placebo-controlled, phase 2 trial. Lancet Neurol 15:259\u2013269. \n                        https:\/\/doi.org\/10.1016\/S1474-4422(16)00004-1","journal-title":"Lancet Neurol"},{"key":"444_CR87","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1177\/1352458515593406","volume":"22","author":"S Ramanathan","year":"2016","unstructured":"Ramanathan S, Prelog K, Barnes EH et al (2016) Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler 22:470\u2013482. \n                        https:\/\/doi.org\/10.1177\/1352458515593406","journal-title":"Mult Scler"},{"key":"444_CR88","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1177\/1352458514551452","volume":"21","author":"N Raz","year":"2015","unstructured":"Raz N, Bick AS, Ben-Hur T, Levin N (2015) Focal demyelinative damage and neighboring white matter integrity: an optic neuritis study. Mult Scler 21:562\u2013571. \n                        https:\/\/doi.org\/10.1177\/1352458514551452","journal-title":"Mult Scler"},{"key":"444_CR89","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4419-1672-3","volume-title":"M\u00fcller cells in the healthy and diseased retina","author":"A Reichenbach","year":"2010","unstructured":"Reichenbach A, Bringmann A (2010) M\u00fcller cells in the healthy and diseased retina. Springer, New York"},{"key":"444_CR90","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1212\/NXI.0000000000000060","volume":"2","author":"M Reindl","year":"2015","unstructured":"Reindl M, Rostasy K (2015) MOG antibody-associated diseases. Neurol Neuroimmunol Neuroinflamm 2:e60. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000060","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR91","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1177\/1352458513503053","volume":"20","author":"M Ringelstein","year":"2014","unstructured":"Ringelstein M, Kleiter I, Ayzenberg I et\u00a0al (2014) Visual evoked potentials in neuromyelitis optica and its spectrum disorders. Mult Scler 20:617\u2013620. \n                        https:\/\/doi.org\/10.1177\/1352458513503053","journal-title":"Mult Scler"},{"key":"444_CR92","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S1474-4422(12)70213-2","volume":"11","author":"S Saidha","year":"2012","unstructured":"Saidha S, Sotirchos ES, Ibrahim MA et\u00a0al (2012) Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a\u00a0retrospective study. Lancet Neurol 11:963\u2013972. \n                        https:\/\/doi.org\/10.1016\/S1474-4422(12)70213-2","journal-title":"Lancet Neurol"},{"key":"444_CR93","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1001\/jamaneurol.2013.573","volume":"70","author":"S Saidha","year":"2013","unstructured":"Saidha S, Sotirchos ES, Oh J et\u00a0al (2013) Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol 70:34\u201343. \n                        https:\/\/doi.org\/10.1001\/jamaneurol.2013.573","journal-title":"JAMA Neurol"},{"key":"444_CR94","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ana.24487","volume":"78","author":"S Saidha","year":"2015","unstructured":"Saidha S, Al-Louzi O, Ratchford JN et al (2015) Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study. Ann Neurol 78:801\u2013813. \n                        https:\/\/doi.org\/10.1002\/ana.24487","journal-title":"Ann Neurol"},{"key":"444_CR95","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","volume":"82","author":"DK Sato","year":"2014","unstructured":"Sato DK, Callegaro D, Lana-Peixoto MA et al (2014) Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 82:474\u2013481. \n                        https:\/\/doi.org\/10.1212\/WNL.0000000000000101","journal-title":"Neurology"},{"key":"444_CR96","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/1352458514538110","volume":"21","author":"S Schippling","year":"2015","unstructured":"Schippling S, Balk LJ, Costello F et al (2015) Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria. Mult Scler 21:163\u2013170. \n                        https:\/\/doi.org\/10.1177\/1352458514538110","journal-title":"Mult Scler"},{"key":"444_CR97","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.msard.2016.11.008","volume":"11","author":"F Schmidt","year":"2017","unstructured":"Schmidt F, Zimmermann H, Mikolajczak J et al (2017) Severe structural and functional visual system damage leads to profound loss of vision-related quality of life in patients with neuromyelitis optica spectrum disorders. Mult Scler Relat Disord 11:45\u201350. \n                        https:\/\/doi.org\/10.1016\/j.msard.2016.11.008","journal-title":"Mult Scler Relat Disord"},{"key":"444_CR98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066151","author":"E Schneider","year":"2013","unstructured":"Schneider E, Zimmermann H, Oberwahrenbrock T et\u00a0al (2013) Optical coherence tomography reveals distinct patterns of retinal damage in neuromyelitis optica and multiple sclerosis. PLOS ONE. \n                        https:\/\/doi.org\/10.1371\/journal.pone.0066151","journal-title":"PLOS ONE"},{"key":"444_CR99","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1212\/WNL.0b013e3182648bc8","volume":"79","author":"T Sinnecker","year":"2012","unstructured":"Sinnecker T, D\u00f6rr J, Pfueller CF et al (2012) Distinct lesion morphology at 7\u2011T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology 79:708\u2013714. \n                        https:\/\/doi.org\/10.1212\/WNL.0b013e3182648bc8","journal-title":"Neurology"},{"key":"444_CR100","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s00330-014-3358-8","volume":"25","author":"T Sinnecker","year":"2015","unstructured":"Sinnecker T, Oberwahrenbrock T, Metz I et al (2015) Optic radiation damage in multiple sclerosis is associated with visual dysfunction and retinal thinning \u2013 an ultrahigh-field MR pilot study. Eur Radiol 25:122\u2013131. \n                        https:\/\/doi.org\/10.1007\/s00330-014-3358-8","journal-title":"Eur Radiol"},{"key":"444_CR101","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1212\/NXI.0000000000000259","volume":"3","author":"T Sinnecker","year":"2016","unstructured":"Sinnecker T, Schumacher S, Mueller K et\u00a0al (2016) MRI phase changes in multiple sclerosis vs neuromyelitis optica lesions at 7\u202fT. Neurol Neuroimmunol Neuroinflamm 3:e259. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000259","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR102","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1212\/WNL.0b013e31828c2f7a","volume":"80","author":"ES Sotirchos","year":"2013","unstructured":"Sotirchos ES, Saidha S, Byraiah G et\u00a0al (2013) In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology 80:1406\u20131414. \n                        https:\/\/doi.org\/10.1212\/WNL.0b013e31828c2f7a","journal-title":"Neurology"},{"key":"444_CR103","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1212\/NXI.0000000000000257","volume":"3","author":"M Spadaro","year":"2016","unstructured":"Spadaro M, Gerdes LA, Krumbholz M et\u00a0al (2016) Autoantibodies to MOG in a\u00a0distinct subgroup of adult multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 3:e257. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000257","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR104","doi-asserted-by":"publisher","first-page":"e276","DOI":"10.1212\/NXI.0000000000000276","volume":"3","author":"L Steinman","year":"2016","unstructured":"Steinman L, Bar-Or A, Behne JM et al (2016) Restoring immune tolerance in neuromyelitis optica: Part I. Neurol Neuroimmunol Neuroinflamm 3:e276. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000276","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR105","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1136\/jnnp-2017-315603","volume":"88","author":"J-P Stellmann","year":"2017","unstructured":"Stellmann J\u2011P, Krumbholz M, Friede T et al (2017) Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response. J\u00a0Neurol Neurosurg Psychiatr 88:639\u2013647. \n                        https:\/\/doi.org\/10.1136\/jnnp-2017-315603","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"444_CR106","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/ana.23573","volume":"72","author":"K-W S\u00fchs","year":"2012","unstructured":"S\u00fchs K\u2011W, Hein K, S\u00e4ttler MB et al (2012) A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis. Ann Neurol 72:199\u2013210. \n                        https:\/\/doi.org\/10.1002\/ana.23573","journal-title":"Ann Neurol"},{"key":"444_CR107","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1364\/OL.18.001864","volume":"18","author":"EA Swanson","year":"1993","unstructured":"Swanson EA, Izatt JA, Hee MR et\u00a0al (1993) In vivo retinal imaging by optical coherence tomography. Opt Lett 18:1864\u20131866","journal-title":"Opt Lett"},{"key":"444_CR108","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/brain\/awr264","volume":"135","author":"SB Syc","year":"2012","unstructured":"Syc SB, Saidha S, Newsome SD et\u00a0al (2012) Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain 135:521\u2013533. \n                        https:\/\/doi.org\/10.1093\/brain\/awr264","journal-title":"Brain"},{"key":"444_CR109","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.1212\/NXI.0000000000000311","volume":"4","author":"Y Takeshita","year":"2017","unstructured":"Takeshita Y, Obermeier B, Cotleur AC et al (2017) Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro. Neurol Neuroimmunol Neuroinflamm 4:e311. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000311","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR110","doi-asserted-by":"publisher","first-page":"e34823","DOI":"10.1371\/journal.pone.0034823","volume":"7","author":"P Tewarie","year":"2012","unstructured":"Tewarie P, Balk L, Costello F et al (2012) The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLOS ONE 7:e34823. \n                        https:\/\/doi.org\/10.1371\/journal.pone.0034823","journal-title":"PLOS ONE"},{"key":"444_CR111","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517727604","author":"D-C Tian","year":"2017","unstructured":"Tian D\u2011C, Su L, Fan M et al (2017) Bidirectional degeneration in the visual pathway in neuromyelitis optica spectrum disorder (NMOSD). Mult Scler. \n                        https:\/\/doi.org\/10.1177\/1352458517727604","journal-title":"Mult Scler"},{"key":"444_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-013-7169-7","volume":"261","author":"C Trebst","year":"2014","unstructured":"Trebst C, Jarius S, Berthele A et\u00a0al (2014) Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J\u00a0Neurol 261:1\u201316. \n                        https:\/\/doi.org\/10.1007\/s00415-013-7169-7","journal-title":"J Neurol"},{"key":"444_CR113","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.ophtha.2011.11.032","volume":"119","author":"SD Walter","year":"2012","unstructured":"Walter SD, Ishikawa H, Galetta KM et\u00a0al (2012) Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology 119:1250\u20131257. \n                        https:\/\/doi.org\/10.1016\/j.ophtha.2011.11.032","journal-title":"Ophthalmology"},{"key":"444_CR114","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1212\/NXI.0000000000000089","volume":"2","author":"P Waters","year":"2015","unstructured":"Waters P, Woodhall M, O\u2019Connor KC et al (2015) MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm 2:e89. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000089","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR115","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1136\/jnnp-2015-312601","volume":"87","author":"P Waters","year":"2016","unstructured":"Waters P, Reindl M, Saiz A et al (2016) Multicentre comparison of a\u00a0diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica. J\u00a0Neurol Neurosurg Psychiatr 87:1005\u20131015. \n                        https:\/\/doi.org\/10.1136\/jnnp-2015-312601","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"444_CR116","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1212\/WNL.0000000000001520","volume":"84","author":"BG Weinshenker","year":"2015","unstructured":"Weinshenker BG, Barron G, Behne JM et\u00a0al (2015) Challenges and opportunities in designing clinical trials for neuromyelitis optica. Neurology 84:1805\u20131815. \n                        https:\/\/doi.org\/10.1212\/WNL.0000000000001520","journal-title":"Neurology"},{"key":"444_CR117","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s00115-012-3602-x","volume":"84","author":"B Wildemann","year":"2013","unstructured":"Wildemann B, Jarius S, Paul F (2013) Neuromyelitis optica. Nervenarzt 84:436\u2013441. \n                        https:\/\/doi.org\/10.1007\/s00115-012-3602-x","journal-title":"Nervenarzt"},{"key":"444_CR118","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1212\/01.WNL.0000049912.02954.2C","volume":"60","author":"DM Wingerchuk","year":"2003","unstructured":"Wingerchuk DM, Weinshenker BG (2003) Neuromyelitis optica: clinical predictors of a\u00a0relapsing course and survival. Neurology 60:848\u2013853","journal-title":"Neurology"},{"key":"444_CR119","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuk","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O\u2019Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic\u2019s syndrome). Neurology 53:1107\u20131114","journal-title":"Neurology"},{"key":"444_CR120","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL et\u00a0al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177\u2013189. \n                        https:\/\/doi.org\/10.1212\/WNL.0000000000001729","journal-title":"Neurology"},{"key":"444_CR121","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1212\/NXI.0000000000000347","volume":"4","author":"T Yamamura","year":"2017","unstructured":"Yamamura T, Nakashima I (2017) Foveal thinning in neuromyelitis optica: A sign of retinal astrocytopathy? Neurol Neuroimmunol Neuroinflamm 4:e347. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000347","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR122","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.2144\/000112090","volume":"39","author":"Z Yaqoob","year":"2005","unstructured":"Yaqoob Z, Wu J, Yang C (2005) Spectral domain optical coherence tomography: a\u00a0better OCT imaging strategy. BioTechniques 39:S6\u2013S13. \n                        https:\/\/doi.org\/10.2144\/000112090","journal-title":"BioTechniques"},{"key":"444_CR123","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1212\/NXI.0000000000000062","volume":"2","author":"SS Zamvil","year":"2015","unstructured":"Zamvil SS, Slavin AJ (2015) Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a\u00a0diagnosis of NMO spectrum disorder? Neurol Neuroimmunol Neuroinflamm 2:e62. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000062","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR124","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1212\/NXI.0000000000000110","volume":"2","author":"A Zekeridou","year":"2015","unstructured":"Zekeridou A, Lennon VA (2015) Aquaporin-4 autoimmunity. Neurol Neuroimmunol Neuroinflamm 2:e110. \n                        https:\/\/doi.org\/10.1212\/NXI.0000000000000110","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"444_CR125","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1177\/1352458514522103","volume":"20","author":"S Zhao","year":"2014","unstructured":"Zhao S, Mutch K, Elsone L et\u00a0al (2014) Neuropathic pain in neuromyelitis optica affects activities of daily living and quality of life. Mult Scler 20:1658\u20131661. \n                        https:\/\/doi.org\/10.1177\/1352458514522103","journal-title":"Mult Scler"},{"key":"444_CR126","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1177\/1352458512457844","volume":"19","author":"H Zimmermann","year":"2013","unstructured":"Zimmermann H, Freing A, Kaufhold F et\u00a0al (2013) Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations. Mult Scler 19:443\u2013450. \n                        https:\/\/doi.org\/10.1177\/1352458512457844","journal-title":"Mult Scler"},{"key":"444_CR127","doi-asserted-by":"publisher","DOI":"10.2147\/DNND.S73506","author":"H Zimmermann","year":"2014","unstructured":"Zimmermann H, Oberwahrenbrock T, Brandt AU et\u00a0al (2014) Optical coherence tomography for retinal imaging in multiple sclerosis. Degener Neurol Neuromuscul Dis. \n                        https:\/\/doi.org\/10.2147\/DNND.S73506","journal-title":"Degener Neurol Neuromuscul Dis"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-017-0444-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-017-0444-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-017-0444-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T03:08:01Z","timestamp":1512356881000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-017-0444-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,8]]},"references-count":127,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["444"],"URL":"https:\/\/doi.org\/10.1007\/s00115-017-0444-6","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,8]]}}}